Clinical molecular pathology analysis has become an indispensable laboratory tool that can be used to characterise tumour biology and drive therapeutic decisions. Could genetic testing help you get a clear picture of what’s potentially driving tumour growth in your patients?
The potential benefits of routine genetic sequencing in metastatic tumours are recognised by guidelines
Common tests used to detect genetic alterations include both NGS and real-time polymerase chain reaction (PCR)
Learn more about FGFR alterations in oncology and their importance in UC: